NewsBenzingaIambic Therapeutics Q3 EPS $(8.52) Misses $(0.72) Estimate, Sales $11.351M Miss $15.133M Estimate Iambic Therapeutics Q3 EPS $(8.52) Misses $(0.72) Estimate, Sales $11.351M Miss $15.133M Estimate Benzinga 2026.11.16 13:44 (GMT+0) Open on Benzinga Other news Freedom Broker Maintains Buy on XPeng, Lowers Price Target to $20 Plug Power Shares Slide Toward 52-Week Low Despite New 280-MW Texas Deal Nvidia Vs. Anthropic: Can the AI IPO Challenge Nvidia’s Dominance Across ETFs? Freedom Broker Maintains Buy on Allot, Lowers Price Target to $12.7 Freedom Broker Maintains Hold on Skydance, Lowers Price Target to $8.5 Freedom Broker Upgrades M-Tron Industries to Buy, Lowers Price Target to $84